The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Roche
 
Consulting or Advisory Role - Amgen; Biocartis; Chrysalis Biomedical Advisors; COMM Santé; Lilly; Pierre Fabre; Sanofi; SERVIER; SERVIER
Bevacizumab in first-line therapy in lung metastases of colorectal cancer: An ARCAD pooled analysis.
 
Einat S Shmueli
Consulting or Advisory Role - AstraZeneca; Medison; MSD; Roche
Travel, Accommodations, Expenses - Medison (Inst); MSD (Inst)
 
Morteza Raeisi
No Relationships to Disclose
 
Benoist Chibaudel
No Relationships to Disclose
 
Herbert Hurwitz
No Relationships to Disclose
 
Leonard B. Saltz
Consulting or Advisory Role - Genor BioPharma
Research Funding - Taiho Pharmaceutical
 
Fairooz F. Kabbinavar
No Relationships to Disclose
 
Niall C. Tebbutt
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Merck; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Pierre Fabre
Speakers' Bureau - Eisai
 
Axel Grothey
Honoraria - Aptitude Health; Elsevier; IMEDEX
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech/Roche; Lilly (Inst); OBI Pharma
Research Funding - Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; Genentech/Roche
 
Richard Adams
Honoraria - Amgen; AstraZeneca; Bayer; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; SERVIER
Speakers' Bureau - Merck Serono
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; SERVIER
 
John Raymond Zalcberg
Leadership - ICON Group; Lipotek
Stock and Other Ownership Interests - Amarin Corporation; Biomarin; Concert Pharmaceuticals; Frequency Therapeutics; Gilead Sciences; Madrigal Pharmaceuticals; Moderna Therapeutics; Novavax; Opthea; Orphazyme; Twist Bioscience; UniQure; Zogenix
Honoraria - Deciphera; Gilead Sciences; Halozyme; Merck Serono; MSD Oncology; Specialised Therapeutics; Targovax; Viatris
Consulting or Advisory Role - 1Globe Health Institute; Alloplex Biotherapeutics Inc; Center for Emerging & Neglected Diseases (CEND); Deciphera; FivePHusion; Genor BioPharma; Lisata; Merck Sharp & Dohme; NOUS Group; Novotech; Revolution Medicines; Specialised Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); IQvia (Inst); Medtronic (Inst); MSD Oncology (Inst); Mylan (Inst); Pfizer (Inst)
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Merck; MSD K.K.; Ono Pharmaceutical
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Genomedia (Inst); MSD (Inst); Nippon Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst)
 
Jean-Baptiste Bachet
Honoraria - Amgen; AstraZeneca; Bayer; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Sanofi; SERVIER; Viatris
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca; Bayer; Merck Serono; Pierre Fabre; Servier
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Servier
 
Romain Cohen
Honoraria - Bristol-Myers Squibb; MSD Oncology; Mylan; Pierre Fabre; SERVIER
Consulting or Advisory Role - Enterome; Exeliom Biosciences
Research Funding - SERVIER
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Mylan
 
Lama Sharara
No Relationships to Disclose
 
Thierry Andre
Honoraria - AMGEN; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Serono; Merck Serono; Pierre Fabre; Roche/Genentech; Sanofi; SERVIER; Ventana Medical Systems
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; GamaMabs Pharma; GlaxoSmithKline; Gritstone Bio; Kaleido Biosciences; MSD Oncology; Nordic Bioscience; Pierre Fabre; Seagen; SERVIER; Tesaro; Transgene
Travel, Accommodations, Expenses - MSD Oncology
(OPTIONAL) Uncompensated Relationships - Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group; ARCAD Foundation; ARCAD Foundation; Gercor
 
Qian Shi
Honoraria - Chugai Pharma
Consulting or Advisory Role - Boehringer Ingelheim; Hoosier Cancer Research Network; Kronos Bio; Regeneron; Yiviva
Research Funding - BMS (Inst); Celgene (Inst); Janssen (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Aimery De Gramont
No Relationships to Disclose